What The White House Is NOT Telling You About The "Green Revolution."
Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.
Read The Full Story On This "Gold Rush"

PALI Insider Trading (Palisade Bio)

Insider Ownership Percentage: 2.11%
Insider Buying (Last 12 Months): $68,483.96
Insider Selling (Last 12 Months): $0.00

Palisade Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Palisade Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Palisade Bio Share Price & Price History

Current Price: $2.71
Price Change: Price Increase of +0.08 (3.04%)
As of 10/19/2021 01:00 AM ET

This chart shows the closing price history over time for PALI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
What The White House Is NOT Telling You About The "Green Revolution."
Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.
Read The Full Story On This "Gold Rush"

Palisade Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/21/2021John David FinleyCFOBuy2,000$2.44$4,880.00View SEC Filing Icon  
9/21/2021Thomas HallamCEOBuy6,000$2.49$14,940.00View SEC Filing Icon  
9/9/2021Robert J TrenschelDirectorBuy3,400$2.89$9,826.001,750View SEC Filing Icon  
9/7/2021Robert J TrenschelDirectorBuy2,707$2.78$7,525.46View SEC Filing Icon  
8/31/2021Robert J. TrenschelDirectorBuy1,750$2.75$4,812.501,750View SEC Filing Icon  
8/27/2021John David FinleyCFOBuy10,000$2.65$26,500.00View SEC Filing Icon  
See Full Table
Insider Trading at Palisade Bio?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Palisade Bio and related companies.

SEC Filings (Institutional Ownership Changes) for Palisade Bio (NASDAQ:PALI)

90.33% of Palisade Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PALI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Palisade Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/17/2021Virtu Financial LLC18,200$74K0.0%N/A0.160%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC10,425$42K0.0%N/A0.362%Search for SEC Filing on Google Icon
8/16/2021State Street Corp28,210$0.12M0.0%N/A0.978%Search for SEC Filing on Google Icon
8/16/2021Sabby Management LLC52,500$0.21M0.0%N/A1.821%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC145,300$0.59M0.0%N/A5.040%Search for SEC Filing on Google Icon
8/13/2021Altium Capital Management LP1,824,894$7.43M1.7%N/A63.298%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC24,675$100K0.0%N/A0.856%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.237,811$0.97M0.0%N/A8.249%Search for SEC Filing on Google Icon
8/12/2021Private Advisor Group LLC21,051$86K0.0%N/A0.730%Search for SEC Filing on Google Icon
8/6/2021HighTower Advisors LLC16,666$68K0.0%N/A0.578%Search for SEC Filing on Google Icon
7/31/2021Strategic Wealth Designers53,129$0.22M0.1%N/A1.845%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Palisade Bio logo
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company is headquartered in Carlsbad, CA.
Read More on Palisade Bio

Today's Range

Now: $2.71
Low: $2.61
High: $2.71

50 Day Range

MA: $2.63
Low: $2.35
High: $3.00

52 Week Range

Now: $2.71
Low: $2.27
High: $16.02

Volume

78,225 shs

Average Volume

795,377 shs

Market Capitalization

$35.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.85

Who are the company insiders with the largest holdings of Palisade Bio?

Palisade Bio's top insider investors include:
  1. Robert J Trenschel (Director)
  2. John David Finley (CFO)
  3. Thomas Hallam (CEO)
What The White House Is NOT Telling You About The "Green Revolution."
Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.
Read The Full Story On This "Gold Rush"